Platelet inhibition with cangrelor and crushed ticagrelor in patients with ST-segment–elevation myocardial infarction undergoing primary percutaneous coronary …

F Franchi, F Rollini, A Rivas, M Wali, M Briceno… - Circulation, 2019 - Am Heart Assoc
Background: The platelet inhibitory effects induced by oral P2Y12 receptor antagonists are
delayed in patients with ST-segment–elevation myocardial infarction undergoing primary …

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary …

F Franchi, F Rollini, A Rivas, M Wali, M Briceno… - Circulation, 2019 - europepmc.org
Background The platelet inhibitory effects induced by oral P2Y 12 receptor antagonists are
delayed in patients with ST-segment-elevation myocardial infarction undergoing primary …

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary …

F Franchi, F Rollini, A Rivas, M Wali, M Briceno… - 2019 - pubmed.ncbi.nlm.nih.gov
Background The platelet inhibitory effects induced by oral P2Y 12 receptor antagonists are
delayed in patients with ST-segment-elevation myocardial infarction undergoing primary …

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary …

F Franchi, F Rollini, A Rivas, M Wali, M Briceno… - Circulation, 2019 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> The platelet inhibitory effects
induced by oral P2Y< jats: sub> 12</jats: sub> receptor antagonists are delayed in patients …